BRIEF-Filana Therapeutics – FDA Lifts Clinical Hold On Filana's Simufilam For TSC-Related Epilepsy

2

Sept 22 (Reuters) – Filana Therapeutics, Inc.: * FILANA THERAPEUTICS ANNOUNCES FDA LIFT OF CLINICAL HOLD ON SIMUFILAM, ENABLING PHASE 2A STUDY IN TSC-RELATED EPILEPSY * FILANA THERAPEUTICS, – FDA

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)